Foreign Subsidiary

In 2002, Taiho Parma U.S.A., Inc., was established as the US subsidiary of Taiho Pharmaceutical Co., Ltd., to provide direct management of research and development programs in obtaining marketing approvals of anticancer drugs in US and European markets.The carefully selected team of professionals maintains close contact with medical professionals and organizations in the US and Europe, while cooperating with Taiho Pharmaceutical staff in Japan, and also develops new drugs, which contribute to cancer treatment throughout the world.